Exercise Controls Tumor Cell Growth Through AMPK Activation
- Conditions
- Breast Cancer
- Registration Number
- NCT01376583
- Lead Sponsor
- Rigshospitalet, Denmark
- Brief Summary
The study investigates the explanation for the positive relation found between exercise and breastcancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 10
Inclusion Criteria
- Healthy Females age 18-30
- BMI 18-25
- Regular period
Exclusion Criteria
- Ingestions of any hormones
- Pregnancy
- Chronic inflammation
- Elite athletes
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link AMPK activation to breast cancer tumor suppression in NCT01376583?
How does exercise-induced AMPK activation compare to metformin in breast cancer treatment?
What biomarkers correlate with exercise efficacy in breast cancer patients per NCT01376583?
Are there adverse events associated with AMPK activation through exercise in cancer patients?
What combination therapies leverage AMPK pathways alongside standard breast cancer treatments?
Trial Locations
- Locations (1)
Centre of Inflammation and Metabolism
🇩🇰Copenhagen, Denmark
Centre of Inflammation and Metabolism🇩🇰Copenhagen, Denmark